Efficacy News and Research

RSS
Reovirus with paclitaxel, carboplatin can treat metastatic non-small cell lung cancer

Reovirus with paclitaxel, carboplatin can treat metastatic non-small cell lung cancer

Meda presents new positive results from Dymista Phase-III trial on AR at EAACI 2011

Meda presents new positive results from Dymista Phase-III trial on AR at EAACI 2011

Biomoda receives U.S. patent to expand the use of CyPath assay for treatment of cancer

Biomoda receives U.S. patent to expand the use of CyPath assay for treatment of cancer

PDR launches new online network to collect, distribute adverse drug events in the U.S.

PDR launches new online network to collect, distribute adverse drug events in the U.S.

Interventions can buffer caregivers from stresses faced in providing care to terminally ill patients

Interventions can buffer caregivers from stresses faced in providing care to terminally ill patients

Sangart commences MP4OX Phase 2b study in acute traumatic injury

Sangart commences MP4OX Phase 2b study in acute traumatic injury

CorMedix completes enrollment in CRMD001 Phase II trial for treatment of acute kidney injury

CorMedix completes enrollment in CRMD001 Phase II trial for treatment of acute kidney injury

TWi Biotech enrolls over 50% of patients for AC-201 Phase IIb trial against Type II Diabetes

TWi Biotech enrolls over 50% of patients for AC-201 Phase IIb trial against Type II Diabetes

GE Healthcare announces results of Optison heart ultrasound contrast agent presented at ASE

GE Healthcare announces results of Optison heart ultrasound contrast agent presented at ASE

Cinryze data on hereditary angioedema presented at EAACI 2011

Cinryze data on hereditary angioedema presented at EAACI 2011

Astellas, Ambit Biosciences announce interim results from AC220 Phase 2 trial against AML

Astellas, Ambit Biosciences announce interim results from AC220 Phase 2 trial against AML

Positive preliminary results from CytRx bafetinib Phase 2 trial for relapsed B-cell chronic lymphocytic leukemia

Positive preliminary results from CytRx bafetinib Phase 2 trial for relapsed B-cell chronic lymphocytic leukemia

Alios, Vertex sign worldwide license agreement to develop new hepatitis C combination medicines

Alios, Vertex sign worldwide license agreement to develop new hepatitis C combination medicines

Millennium reports results from two MLN9708 ongoing Phase I studies on multiple myeloma

Millennium reports results from two MLN9708 ongoing Phase I studies on multiple myeloma

FDA approves Valeant's Potiga Tablets for treatment of partial-onset seizures

FDA approves Valeant's Potiga Tablets for treatment of partial-onset seizures

Final data from Alexion's Soliris Phase 2 studies on aHUS presented at EHA 2011

Final data from Alexion's Soliris Phase 2 studies on aHUS presented at EHA 2011

New opportunities to save another 6.4 million lives

New opportunities to save another 6.4 million lives

Blinatumomab phase 2 trial results on acute lymphoblastic leukemia to be presented at EHA 2011

Blinatumomab phase 2 trial results on acute lymphoblastic leukemia to be presented at EHA 2011

Scripps Research receives $2.2M NIH grant to develop novel therapeutics for substance abuse

Scripps Research receives $2.2M NIH grant to develop novel therapeutics for substance abuse

Neoprobe's Lymphoseek Phase 3 trial data presented at SNM annual meeting

Neoprobe's Lymphoseek Phase 3 trial data presented at SNM annual meeting

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.